Athersys (NASDAQ:ATHX) will report earnings after markets close on Tuesday, August 13th. Athersys Incorporated is a biotechnology company. The Company has developed technologies that will help identify gene and related proteins and create synthetic human chromosomes.
Here is your Cheat Sheet to Athersys Earnings:
Earnings Expectations: Analysts expect earnings of $-0.12 per share on revenues of $390.00K.
Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a loss of $0.12 and has not changed. For the current year, the average estimate is a loss of $0.52, which is worse than the estimate ninety days ago.
Here’s how Athersys has been performing on an annual basis:
|Revenue ($) in millions||3||2||9||10||9|
|Diluted EPS ($)||-0.95||-0.81||-0.60||-0.59||-0.45|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||2.66||1.01||2.29||0.33|
|Diluted EPS ($)||-0.13||-0.12||-0.07||-0.18|
Athersys has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)